Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALTA: MenC Vaccine Schedules and Injection Site Study in Infants
NCT01129518Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jun 2010
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal serogroup C conjugate vaccine in invasive meningococcal disease (IMD), sponsored by University of Oxford. Started Jun 2010; status: completed.
02
Drugs
meningococcal serogroup C conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT01129518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129518.